Market revenue in 2021 | USD 760.1 million |
Market revenue in 2028 | USD 1,191.4 million |
Growth rate | 6.6% (CAGR from 2021 to 2028) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.25% in 2021. Horizon Databook has segmented the Italy immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Favorable government initiatives, an increasing number of independent diagnostic centers, high prevalence of life-threatening diseases that require efficient tests for screening & treatment have propelled the growth of Italy's immunoassay analyzers market.
As per a study published by the European Journal of Public Health, cardiovascular diseases affect 7.49 million lives and remain the leading cause of mortality, morbidity, and disability in Italy, causing 34.8% of total deaths in 2017.
Neoplasms are the second most significant cause of death, following cardiovascular diseases. According to Globocan, Italy reported 415,269 new cancer cases and 174,759 cancer deaths in 2020. As per a report published by OECD and the European Observatory on Health Systems and Policies, in 2017, one in five adults smoked daily, which exceeded the EU average of 19%.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy immunoassay analyzers market , including forecasts for subscribers. This country databook contains high-level insights into Italy immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account